Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer
Huang Bartlett, Cynthia, Mardekian, Jack, Cotter, Matthew James, Huang, Xin, Zhang, Zhe, Parrinello, Christina M., Bourla, Ariel Bulua, Ganti, Apar KishorVolume:
15
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0227256
Date:
April, 2020
Fichier:
PDF, 1.60 MB
2020
File converter
Plus de résultats de recherche
More benefits 
